Standoff over Eli Lilly 340B Policy Escalates as Company Moves to Nix Discounts for Noncomplying Hospitals
- June 05, 2026
- Written by AHLA Legal Staff
Eli Lilly plans to cut off discounts under the 340B drug pricing program to hospitals that fail to comply with its recent policy requiring them to submit claims-level data for all dispensation of the company's drugs, regardless of setting.
ARTICLE TAGS
You must be logged in to access this content.